Table 2.
The blood tests data of study participants.
| Baseline | End of 1st wk PBM + H2 water | End of 2nd wk PBM + H2 water | Cessation of therapy for 1 wk | |
| BUN (mg/dL) | 15.71 ± 3.58 | 14.94 ± 3.88 | 14.24 ± 3.35 | 14.18 ± 3.20 |
| Creatinine (mg/dL) | 0.92 ± 0.23 | 0.92 ± 0.23 | 0.92 ± 0.25 | 0.91 ± 0.22 |
| GOT (U/L) | 24.35 ± 4.03 | 22.59 ± 4.03 | 23.71 ± 6.04 | 23.65 ± 5.28 |
| GPT (U/L) | 20.47 ± 8.32 | 19.41 ± 9.37 | 18.12 ± 7.71 | 18.76 ± 8.44 |
| WBC (103/uL) | 5.85 ± 1.01 | 6.12 ± 0.91 | 5.92 ± 1.05 | 6.04 ± 1.17 |
| Hb (g/dL) | 13.56 ± 1.71 | 13.89 ± 1.58 | 13.66 ± 1.58 | 13.63 ± 1.70 |
| PLT (103/uL) | 193.5 ± 60.2 | 198.9 ± 55.4 | 198.9 ± 54.9 | 203.6 ± 61.2 |
BUN = blood urea nitrogen, GOT = glutamic-oxalocetic transaminase, GPT = glutamic-pyruvic transaminase, Hb = haemoglobin, PLT = platelet, WBC = white blood cell.